lobbying_activities: 2954095

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2954095	41c2c234-c438-4d1b-b89d-f061a8e1312c	1T	AMRYT PHARMA	401106521	AMRYT PHARMA	2023	first_quarter	HCR	Issues related to rare disease innovation including the HEART ACT (HR 7667) and the BENEFIT Act (HR4472).	HOUSE OF REPRESENTATIVES,SENATE		30000	0	1	2023-03-03T13:18:56-05:00